The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Yes Danny you are correct. There has not been any recent director buying recently. The point FK1 was making was that we are perhaps lucky the price has not fallen further with the 5 million sold on one day last week. Wonder for how long the brokers are prepared absorb shares at the 1.21-1,22 level ? Would be nice if they have a large buy to cover.
I cannot understand the recent trades either FK1. And cannot get any clarity from the management .
As of 1000 this morning dummy trades for 100,000 are showing me a buying price of 1.25 and for selling it's 1.22 so a nice tight spread, but no trades !
Blue. Interesting and thought provoking post. What do we really know about the country and our invetment.
They are good at football .The majority as muslims. Are our selling prices low because we are straining to compete with Palmci/Sifca/Sania who have far more financial muscle than Dekel can ever have. Are we paying our producers lower prices to reflect local sales as has been suggested so effectively maintaining our 'profit' . Is the board focussing too much on Firering and Lithium. What is the true story about the failure of the machinery for the cashews and what action are we taking against the Italian supplier.
Russ. Seems daft to me but this share is a long term hold.
Annual results really warrant a drop of over £ 2.50 a share ?
Maybe we should invite the China State Regulatory lot to have a look at AIM !
Market reaction to what I see as positive news.